Sidley Austin adds ex-FDA counsel Troy
Former FDA Chief Counsel Dan Troy and Special Assistant Coleen Klaismeier join Sidley Austin Brown & Wood's life sciences practice. Troy will also serve in the appellate litigation division. Troy and Klaismeier left FDA in December; Troy was the first political appointee at FDA in the Bush Administration (1"The Pink Sheet" Nov. 22, 2004, p. 15)...
You may also be interested in...
FDA will continue to protect its regulatory authority by supporting federal preeminence in state product liability suits following the departure of Chief Counsel Dan Troy, Acting Commissioner Lester Crawford said
Fresenius Kabi must pay Eli Lilly €28m in damages after a French court of first instance found that the generics firm’s pemetrexed infringed intellectual property protecting the Alimta chemotherapy brand. The German firm has commented on possible next steps.
Japanese ophthalmic specialist picks up young private US firm and gains a small but broad set of marketed products.